PR Newswire ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China by March 24, 2025
PR Newswire Registration is On! 2025 CWIEME Shanghai – Your Gateway to Innovation & Connections by March 24, 2025
PR Newswire Asia’s First Single Stock Leveraged & Inverse Products to Debut on HKEX by March 24, 2025
PR Newswire CROSSFIRE REBRANDS TO JENSEN HUGHES, EXPANDING ITS FIRE SAFETY AND PERFORMANCE-BASED DESIGN ENGINEERING OFFERINGS by March 23, 2025
PR Newswire Hyundai Capital Australia Obtains Its First Credit Rating of ‘A-‘ from S&P Global Ratings by March 23, 2025
PR Newswire Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence by March 23, 2025
PR Newswire AV-Comparatives Launches Groundbreaking EDR Detection Validation Test — Kaspersky Next EDR Expert Achieves Certification in Inaugural Assessment by March 23, 2025
PR Newswire Bybit Named Exclusive Payment Partner for Tomorrowland Brasil 2025-26, Launches Cardholder Presale by March 23, 2025
